Delivery Order SPE2DB22D1017-SPE2DB25FH0CX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,027.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is firm fixed price with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,120.37 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,130.18 for Dexcom G7 sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $3,221.99 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The award was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,375.76. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.08 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This firm fixed-price contract, issued on August 7, 2025, is a non-set-aside award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0CXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,415.48 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for continuous glucose monitoring sensors aligns with the company's extensive portfolio of pharmaceutical and medical device deliveries through the DLA Medical Supply Chain. The award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through open competition, as evidenced by its $999.99 billion IDC with DLA Troop Support Medical running through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/19/25 |